Pharmaceuticals

Global Sleeping Pills Market Projected to Expand at 8.1% CAGR by 2029

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Sleeping Pills Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The sleeping pills market size has shown substantial expansion in recent years. It is anticipated to increase from $79.21 billion in 2024 to $85.87 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.4%. This historical growth stems from growing awareness about sleep health, increasing stress and anxiety in daily life, influence of lifestyle changes and urbanization, increasing geriatric population, and rising research and development activities.

The sleeping pills market is anticipated to experience robust expansion in the upcoming years, projected to reach $117.31 billion by 2029 at a compound annual growth rate (CAGR) of 8.1%. This projected growth is primarily driven by factors such as increasing demand for non-addictive options, the development of personalized and targeted sleep therapies, rising investment in biotechnology, stringent regulatory approvals, and the expansion of healthcare infrastructure. Key trends anticipated during the forecast period encompass the utilization of digital biomarkers to tailor sleep medication, the integration of artificial intelligence (AI) and machine learning, breakthroughs in cannabinoid-based sleep therapeutics, nanotechnology for targeted drug delivery, and the emergence of wearable sleep monitoring devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Are The Main Drivers Boosting The Sleeping Pills Industry’s Expansion?

The escalating prevalence of mental illness is projected to fuel the growth of the sleeping pills market moving forward. Mental illness encompasses a wide array of mental health conditions that impact an individual’s mood, thought processes, behavior, and general functioning. The rise in mental illness prevalence is linked to increasing levels of chronic stress, as prolonged stress can disrupt brain function and either trigger or worsen mental health disorders. Sleeping pills contribute to managing mental illness by enhancing sleep quality, which is crucial for emotional and cognitive stability. They help alleviate symptoms of anxiety and depression by facilitating restful sleep and improving overall mental well-being and daily performance. For instance, in 2022, according to the National Institute of Mental Health, a US-based federal government research agency, 59.3 million adults aged 18 and older in the United States had any mental illness (AMI), accounting for 23.1% of the total adult population. Consequently, the increasing prevalence of mental illness is a significant driver for the growth of the sleeping pills market.

What Are The Major Segment Types Covered In The Sleeping Pills Market?

The sleeping pills market covered in this report is segmented –

1) By Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root, Other Herbal Or Natural Supplements

How Are Trends Influencing The Sleeping Pills Market?

Leading companies operating in the sleeping pills market are concentrating on developing advanced compositions, such as novel drug formulations, with the goal of improving sleep quality, minimizing dependency risks, and reducing undesirable side effects. Novel drug formulations signify the creation of new medicinal compounds specifically engineered to enhance efficacy, boost absorption, diminish side effects, and offer more targeted and patient-friendly treatment approaches. For instance, in October 2024, Neurovalens, a UK-based medical device company, unveiled Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device engineered to treat chronic insomnia in adults aged 22 and older. This device functions by utilizing low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas for regulating sleep and circadian rhythms. Users wear the device on their head for 30 minutes each evening, typically 1–2 hours before bedtime, with customizable intensity settings for user comfort. Modius Sleep is user-friendly, portable, and can be worn while undertaking activities such as reading or watching TV.

Which Key Players Are Driving Competition In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographies Are Emerging As Strong Markets For The Sleeping Pills Industry?

North America was the largest region in the sleeping pills market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2025, By The Business Research Company

Sleep Apnea Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795